Università Vita-Salute San Raffaele, Milano, Italy.
J Histochem Cytochem. 2013 Feb;61(2):116-24. doi: 10.1369/0022155412470455. Epub 2012 Nov 19.
Tissue microarray (TMA) and cell microarray (CMA) are two powerful techniques that allow for the immunophenotypical characterization of hundreds of samples simultaneously. In particular, the CMA approach is particularly useful for immunophenotyping new stem cell lines (e.g., cardiac, neural, mesenchymal) using conventional markers, as well as for testing the specificity and the efficacy of newly developed antibodies. We propose the use of a tissue arrayer not only to perform protein expression profiling by immunohistochemistry but also to carry out molecular genetics studies. In fact, starting with several tissues or cell lines, it is possible to obtain the complete signature of each sample, describing the protein, mRNA and microRNA expression, and DNA mutations, or eventually to analyze the epigenetic processes that control protein regulation. Here we show the results obtained using the Galileo CK4500 TMA platform.
组织微阵列(TMA)和细胞微阵列(CMA)是两种强大的技术,可同时对数百个样本进行免疫表型特征分析。特别是,CMA 方法特别适用于使用常规标志物对新的干细胞系(例如心脏、神经、间充质)进行免疫表型分析,以及测试新开发的抗体的特异性和功效。我们建议使用组织芯片仪不仅进行免疫组织化学的蛋白质表达谱分析,还进行分子遗传学研究。实际上,从几种组织或细胞系开始,就有可能获得每个样本的完整特征,描述蛋白质、mRNA 和 microRNA 的表达以及 DNA 突变,或者最终分析控制蛋白质调节的表观遗传过程。在这里,我们展示了使用 Galileo CK4500 TMA 平台获得的结果。